Top

BY Clayton Boldt

Prostate cancer is the most common cancer diagnosed in American men, and the second leading cause of cancer death in men. While hormone-based therapies are effective for many men, there remain an estimated 20% of patients who will not benefit and have significantly worse outcomes.

These patients have a subtype of prostate cancer known as aggressive variant prostate cancer (AVPC), which does not respond to therapies that block...

Ana Aparicio, M.D.

BY Clayton Boldt

For the first time, a new drug from the field of immuno-oncology has proven to extend survival for patients with advanced kidney cancer, a...

BY Clayton Boldt

MD Anderson has appointed former U.S. Public Health Service four-star Admiral Joxel Garcia, M.D. as the inaugural executive director of the...